The Hypercalcemia of Cancer Clinical Implications and Pathogenic Mechanisms

HYPERCALCEMIA is one of the most common metabolic complications of cancer. It has fascinated clinicians since it was first recognized 60 years ago by Zondek et al. 1 It is now being recognized more commonly, as is primary hyperparathyroidism, because of the advent of routine measurement of the serum...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 310; no. 26; pp. 1718 - 1727
Main Authors Mundy, Gregory R, Ibbotson, Kenneth J, D'Souza, Sharyn M, Simpson, Ellen L, Jacobs, John W, Martin, T.John
Format Journal Article
LanguageEnglish
Published Boston, MA Massachusetts Medical Society 28.06.1984
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:HYPERCALCEMIA is one of the most common metabolic complications of cancer. It has fascinated clinicians since it was first recognized 60 years ago by Zondek et al. 1 It is now being recognized more commonly, as is primary hyperparathyroidism, because of the advent of routine measurement of the serum calcium level. 2 , 3 The estimated incidence of the hypercalcemia of cancer is 150 new cases per million persons per year. 2 , 3 This compares with an annual incidence of approximately 250 new cases of primary hyperparathyroidism per year. 2 , 3 However, the relative frequency of cancer as a cause of hypercalcemia is even greater in hospital populations, . . .
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJM198406283102607